Search details
1.
Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer.
Front Biosci
; 12: 2260-8, 2007 Jan 01.
Article
in English
| MEDLINE | ID: mdl-17127462
2.
Quality of life and sexual functioning in cervical cancer survivors.
J Clin Oncol
; 23(30): 7428-36, 2005 Oct 20.
Article
in English
| MEDLINE | ID: mdl-16234510
3.
Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer.
J Clin Oncol
; 21(2): 291-7, 2003 Jan 15.
Article
in English
| MEDLINE | ID: mdl-12525521
4.
4-HPR modulates gene expression in ovarian cells.
Int J Cancer
; 119(5): 1005-13, 2006 Sep 01.
Article
in English
| MEDLINE | ID: mdl-16570282
5.
In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Gynecol Oncol
; 98(2): 182-92, 2005 Aug.
Article
in English
| MEDLINE | ID: mdl-15907982
6.
Rankings and symptom assessments of side effects from chemotherapy: insights from experienced patients with ovarian cancer.
Support Care Cancer
; 13(4): 219-27, 2005 Apr.
Article
in English
| MEDLINE | ID: mdl-15538640
7.
Functional outcomes and complications of continent urinary diversions in patients with gynecologic malignancies.
Gynecol Oncol
; 85(2): 285-91, 2002 May.
Article
in English
| MEDLINE | ID: mdl-11972389
8.
Innovations in the treatment of invasive cervical cancer.
Cancer
; 98(9 Suppl): 2052-63, 2003 Nov 01.
Article
in English
| MEDLINE | ID: mdl-14603542
Results
1 -
8
de 8
1
Next >
>>